1. Articles in category: Other Business News

    25-48 of 1045 « 1 2 3 4 5 ... 42 43 44 »
    1. Zeiss Acquisition of Insight Ophthalmic Laser Engines for 19.1M Euros

      Zeiss Acquisition of Insight Ophthalmic Laser Engines for 19.1M Euros

      On 24 February 2017 a contract was concluded between Carl Zeiss Meditec, Inc., Dublin USA, and Insight Photonics Solutions, Inc. (hereinafter “Insight”), which domiciled in Lafayette, USA, pertaining to the acquisition of 52 percent of the shares in Ophthalmic Laser Engines, LLC, Lafayette, USA (hereinafter referred to as “OLE”). The main aim of acquiring these shares is to develop and produce an akinetic swept source laser for ophthalmology, and the associated OCT system elements. Departing from the voting rights distribution, a profit distribution of 30% for Insight was agreed until 31 December 2022, which allocated as a performance-related component to ...

      Read Full Article
    2. Axsun Hopes to Break Into the 3D Printing Market | 3D Print Plan

      Axsun Hopes to Break Into the 3D Printing Market | 3D Print Plan

      Axsun is a 100-person Boston-based company that specializes in “advanced photonics”, a science involving light and microscopic devices. Their technology uses “Optical Coherence Tomography (OCT)” in a way that could benefit 3D print operations. This technology is well-established in the medical community, where it is used to capture highly detailed images of sub-surface structures in transparent or translucent materials. Normally, this is used to “see” into patients for medical diagnoses. Specialized lasers provide the imaging through materials. However, the theory is that it could also be used in 3D printing. Axsun’s proposition is that this technology could be added ...

      Read Full Article
    3. OncoRes Medical backed by MRCF to develop innovative imaging technology for breast cancer surgery

      OncoRes Medical backed by MRCF to develop innovative imaging technology for breast cancer surgery

      OncoRes Medical Pty Ltd, a new medical device company established to develop an imaging tool to improve the outcome of breast cancer surgery, will receive up to AU$6M of venture capital investment from the Medical Research Commercialisation Fund (MRCF). The funding will go towards developing a handheld imaging probe and console which will provide real-time intraoperative guidance to surgeons by assisting with the delineation of tumour from healthy tissue, at a microscopic level. Breast cancer has the second highest mortality rate of all cancers in women. In 2016 there were approximately 16,000 new cases of breast cancer diagnosed ...

      Read Full Article
    4. Avinger Announces Verified Data of 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease

      Avinger Announces Verified Data of 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease

      Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced positive two-year clinical data from the pivotal VISION study of the company’s Lumivascular™ technology. The VISION study was designed to evaluate the safety and effectiveness of Avinger’s Pantheris® system to perform directional atherectomy while, for the first time ever, allowing physicians to use real-time intravascular imaging to aid in the removal of plaque from diseased lower extremity arteries. Data from the study, which demonstrated successful achievement of all primary and secondary safety and effectiveness endpoints, supported U.S. Food and Drug ...

      Read Full Article
      Mentions: FDA Avinger
    5. NinePoint Medical to Feature the NvisionVLE® Imaging System with Real-time Targeting™ at DDW 2017; Twenty-four Scientific Abstracts to be Presented

      NinePoint Medical to Feature the NvisionVLE® Imaging System with Real-time Targeting™ at DDW 2017; Twenty-four Scientific Abstracts to be Presented

      – NinePoint Medical, Inc., a transformative medical device company pioneering the use of advanced Optical Coherence Tomography (OCT) for gastrointestinal applications, will be featuring the NvisionVLE® Imaging System with Real-time Targeting™ at Digestive Disease Week® (DDW) 2017, which will be held May 6-9 in Chicago. In addition, results from various studies utilizing this technology in gastroenterology will be presented in 24 scientific abstracts throughout the conference. Random biopsy is the current standard of care for diagnosing esophageal diseases such as Barrett’s esophagus, squamous cell carcinoma, and adenocarcinoma. However, random biopsies assess less than 3% of the esophageal surface1 , leaving more ...

      Read Full Article
    6. Pioneering HD updates launched for the AngioVue OCT-A system

      Pioneering HD updates launched for the AngioVue OCT-A system

      Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard optometry and ophthalmic equipment, is pleased to announce the launch of AngioVueHD imaging. This high density OCT Angiography (OCT-A) imaging will provide significant improvement in the resolution and peripheral visualisation of vasculature in the eye. AngioVue HD imaging provides OCT-A scans with 73% more sampling points, providing the user with a 6mm x 6mm scan with outstanding resolution. It also improves image resolution by approximately 33% over the existing field-of-view. The improvements enable physicians to more closely assess the fine vasculature in the eye for changes which could indicate ocular ...

      Read Full Article
      Mentions: Optovue Haag-Streit
    7. Teledyne e2v launches new OctoPlus line scan cameras for Optical Coherence Tomography - e2v

      Teledyne e2v launches new OctoPlus line scan cameras for Optical Coherence Tomography - e2v

      eledyne e2v , the global innovator of imaging solutions, has developed a new range of line scan cameras for Optical Coherence Tomography (OCT) applications in healthcare and industrial markets. The new OctoPlus range will have an immediate impact in ophthalmic OCT by reducing patient examination times and increasing the field of view available to practitioners when carrying out non-invasive eye examinations. OctoPlus was developed following discussions with doctors and medical industry professionals. It is based on new image sensor pixel architecture and is specifically tuned to provide users with the most accurate images of the retina and cornea; mapping tissue structure ...

      Read Full Article
      Mentions: e2v
    8. Damae Medical Raises €2M in Funding

      Damae Medical Raises €2M in Funding

      Damae Medical , a Paris, France-based medtech company, closed a €2m funding. Backers included Kurma Partners, Idinvest Partners, News Invest, Paris-Saclay Seed Fund co-managed by Partech Ventures, and private investors. The company intends to use the funds to finance the development and CE marking of OCTAV®, which is scheduled for mid-2018. Founded in September 2014 by Anaïs Barut, CEO, Damae Medical aims to provide dermatologists with a novel, in vivo imaging technology for a deep look into the skin. This technology enables cellular-resolution imaging of the skin similar to histology, without the need for tissue excision and processing. The company ...

      Read Full Article
    9. OPTOVUE FIRST TO RELEASE HIGH DENSITY OCT ANGIOGRAPHY FOR OPHTHALMOLOGY

      OPTOVUE FIRST TO RELEASE HIGH DENSITY OCT ANGIOGRAPHY FOR OPHTHALMOLOGY

      Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA) , is the first company to offer higher density OCTA imaging that provides significant improvement in resolution and peripheral visualization of vasculature in the eye. AngioVueHD Imaging, commercially released by Optovue today, provides OCTA scans with 73 percent more sampling points* and improves image resolution by approximately 33 percent over the existing field-of-view, enabling physicians to more closely assess the fine vasculature in the eye for changes that could indicate ocular disease. According to Nadia Waheed, M.D., MPH, associate professor of Ophthalmology at Tufts ...

      Read Full Article
    10. Avinger’s Pantheris Named a 2017 Gold Edison Award Winner

      Avinger’s Pantheris Named a 2017 Gold Edison Award Winner

      Avinger, Inc., a leading developer of innovative treatments for peripheral artery disease (PAD), was honored at the 2017 Edison Awards™ in the Medical/Dental Surgical Tool category with gold for Pantheris, the first-ever image-guided atherectomy device for the treatment of PAD. Avinger was nominated among hundreds of the world’s most recognized companies to acknowledge dedication and commitment of innovation to create a positive impact in the world. The ballot of nominees for the Edison Awards was judged by a panel of more than 3,000 leading business executives including past award winners, academics and leaders in the fields of ...

      Read Full Article
    11. Second-Generation OCT Module Goes the Extra Mile

      Second-Generation OCT Module Goes the Extra Mile

      Device features increased speed and higher image contrast. D avid M. Brown, MD, a retinal physician with Retina Consultants of Houston, in Texas, was prompted to upgrade to Heidelberg Engineering’s OCT2 module for the Spectralis diagnostic imaging platform because of its increased scanning speed and throughput. “I increasingly found that the process of obtaining optical coherence tomography (OCT) caused patient flow to bottleneck at my practice,” he says. “The OCT2 module helps to mitigate that issue. I can obtain a complete volume scan within 12 to 15 seconds for each eye that is precisely image tracked to the last ...

      Read Full Article
    12. Avinger to lay off a third of workforce

      Avinger to lay off a third of workforce

      Avinger said yesterday that it plans to lay off a third of its workforce and examine its “strategic alternatives” as it focuses on its Pantheris peripheral artery device. The layoffs, affecting 131 workers, are slated to be complete this week, the Redwood City, Calif.-based company said, including cutting its field sales force by nearly half, from 60 to 32. “The plan is designed to focus the company’s commercial efforts on driving catheter utilization in its strongest markets, around its most productive sales professionals,” Avinger said. “This workforce reduction is designed to reduce operating expenses while continuing to support ...

      Read Full Article
      Mentions: Avinger
    13. Wasatch Photonics’ MicroAngio System

      Wasatch Photonics’ MicroAngio System

      Wasatch Photonics’ MicroAngio technology, specifically designed for research and OEM applications, provides a unique way to image micro vascular structures in living tissue. The technique based on optical coherence tomography (OCT) , requires no external contrast agents, and develops a three-dimensional map of the blood vessels. MicroAngio relies on the intrinsic contrast of red blood cell motion in the vessels. This eliminates the requirement of injecting contrast agents and overcomes the problem of background signal from leaky blood vessels. WP MicroAngio, unlike other OCT angiography systems, is custom designed for the specific application. Signal acquisition and processing for such techniques depend ...

      Read Full Article
    14. The Best Motivations for Photonics Entrepreneurs - An interview with Eric Swanson

      The Best Motivations for Photonics Entrepreneurs - An interview with Eric Swanson

      I figure we have much to learn from a very successful serial photonics entrepreneur, Eric Swanson. Eric is a co-founder or founding board member of five companies: Advanced Ophthalmic Devices, Lightlab Imaging, Sycamore Networks, Acacia Communications, and Curata. These companies have evolved over time and shipped over $1 billion in products worldwide. He is an OSA Fellow, IEEE Fellow, a co-recipient of the 2017 Russ Prize, and an active participant in a variety of volunteer activities. Milton Chang: It is remarkable that OCT has been able to move in 25 years from proof-of-principle to an FDA-approved instrument used pervasively in ...

      Read Full Article
    15. Wasatch Photonics Unleashes Game Changing Spectral-domain OCT Spectrometer

      Wasatch Photonics Unleashes Game Changing Spectral-domain OCT Spectrometer

      Wasatch Photonics Inc. announced its new OCT spectrometer, Cobra-S, offering unbeatable ultra-high speeds of 250,000 lines per second and enhanced roll-off performance for deeper sample penetration with the highest image clarity. The Cobra-S can be designed into near infrared OCT systems for research and OEM applications. A part of the Wasatch Photonics’ industry-leading Cobra spectrometer line, the Cobra-S is designed for a wide variety of spectral-domain OCT applications including ophthalmology, dermatology, angiography, oncology and industrial use. “Cobra-S is the result of our commitment to provide researchers and industry partners with the latest technology that enables and drives new applications ...

      Read Full Article
    16. Avinger Announces 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease

      Avinger Announces 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease

      Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced positive two-year clinical data from the pivotal VISION study of the company’s Lumivascular™ technology. The VISION study was designed to evaluate the safety and effectiveness of Avinger’s Pantheris™ system to perform directional atherectomy while for the first time ever allowing physicians to use real-time intravascular imaging to aid in the removal of plaque from diseased lower extremity arteries. Data from the study, which demonstrated successful achievement of all primary and secondary safety and effectiveness endpoints, supported U.S. Food and Drug ...

      Read Full Article
    17. Luxmux Prism Award Finalist for New Compact Broadband Light Source

      Luxmux Prism Award Finalist for New Compact Broadband Light Source

      LUXMUX Technology Corporation ( Calgary, AB ) announced that that it will introduce its latest product, the BeST-SLED ® broadband light source at the Photonics West exhibition, Booth #4137, to be held from January 28-February 2 at the Moscone Center in San Francisco. The BeST-SLED ® has been selected as a finalist for the PRISM award for photonics innovation because of its' stability, compact size, low cost/performance ratio, wide spectral range and high power. The BeST-SLED ® is a multiple superluminescent diode light source within a single butterfly package that provides up to 50mW of power over the spectral band of 1230nm to 1730nm ...

      Read Full Article
    18. Heidelberg Engineering and Gauss Medical Corporation Establish an Ophthalmic Healthcare IT Joint Venture in China

      Heidelberg Engineering and Gauss Medical Corporation Establish an Ophthalmic Healthcare IT Joint Venture in China

      The joint venture company, Gauss Infomed, will offer Picture Archiving and Communication Systems (PACS) and Electronic Medical Record (EMR) software, along with other related product solutions for the ophthalmology healthcare IT market. Gauss Infomed will operate out of Beijing and through a local network of offices to deliver its services across the entire country. “China is a fast-growing market and it is of great importance to our company” “The establishment of this joint venture with Heidelberg Engineering comes at a time of growing demand for advanced ophthalmic IT solutions in China,” said Mr. Liu Xidong, Chairman and CEO of Gauss ...

      Read Full Article
    19. Avinger Announces New FDA Clearance for Lumivascular Imaging Console, Enabling Vessel Measurement Via Touchscreen

      Avinger Announces New FDA Clearance for Lumivascular Imaging Console, Enabling Vessel Measurement Via Touchscreen

      Technology Upgrade to Lightbox L250 Allows Physicians to Accurately Assess Luminal Gain REDWOOD CITY, Calif., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that the company has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Lightbox L250 imaging console. With this new FDA clearance, the Lightbox L250 now provides detailed measurement of vessels with a few simple taps to a touch screen, helping further improve visualization inside the vessel before, during, and after Pantheris™ Lumivascular atherectomy procedures ...

      Read Full Article
    20. OCT Angiography Module for SPECTRALIS now available outside US

      OCT Angiography Module for SPECTRALIS now available outside US

      The SPECTRALIS ® expandable diagnostic imaging platform can be upgraded with the OCT Angiography Module to perform non-invasive, layer-by-layer examinations of flow in the vascular networks of the retina and choroid. The OCT Angiography Module can be added to new and existing upgradeable SPECTRALIS devices with the OCT2 Module. The multimodal imaging platform allows clinicians to compare OCT angiographies to other modalities such as structural OCT and dye-based angiographies as well as infrared, MultiColor and BluePeak images, dependent on the SPECTRALIS model. “In combination with other imaging modalities, OCT angiography enables a more comprehensive understanding of vascular abnormalities. The SPECTRALIS truly ...

      Read Full Article
    21. Micro-Tech LumiScan Imaging System 510(k) Clearance

      Micro-Tech LumiScan Imaging System 510(k) Clearance

      We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions ...

      Read Full Article
      Mentions: FDA Micro-Tech
    22. Wasatch Photonics MicroAngio, 2017 Prism Award Finalist

      Wasatch Photonics MicroAngio, 2017 Prism Award Finalist

      Wasatch Photonics Inc., a leading provider for gratings, spectrometers and optical coherence tomography instrumentation, is pleased to announce its new 3D MicroAngio technology has been selected as a Prism Award Finalist in the highly competitive Biomedical Instrumentation category. WP MicroAngio was created for high-resolution angiographic imaging for research and original equipment manufacturer (OEM) applications. Unlike other OCT angiography systems, the WP MicroAngio offers custom probe designs for each specific application, such as retina, brain or skin, for the highest quality images. WP software drives the system and provides both 3D images and one-click options for sampling, processing and motion correction ...

      Read Full Article
    23. ZEISS receives the first US FDA Clearance for Swept-Source OCT posterior ocular imaging with PLEX Elite 9000

      ZEISS receives the first US FDA Clearance for Swept-Source OCT posterior ocular imaging with PLEX Elite 9000

      Having received the first US FDA Clearance for OCT Angiography technology in September 2015, the Medical Technology business group of ZEISS now announces receiving the first US FDA Clearance for Swept-Source OCT imaging technology for posterior ocular structures with ZEISS PLEX ® Elite 9000. This powerful, cutting-edge Swept-Source OCT and OCT Angiography platform was designed for advanced retina research and is at the core of the Advanced Retina Imaging (A R I) Network 1 . The A R I Network, led by Philip J. Rosenfeld, MD, PhD, is a unique global consortium of clinicians and scientists from around the world working at ...

      Read Full Article
    25-48 of 1045 « 1 2 3 4 5 ... 42 43 44 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. Organizations in the News

    1. (3 articles) FDA
    2. (1 articles) Cleveland Clinic
  4. People in the News

    1. (1 articles) Justis P. Ehlers
    2. (1 articles) Jon Holmes
    3. (1 articles) Brian K. Courtney
  5. OCT Companies in the News

    1. (2 articles) Exalos
    2. (1 articles) Sciton
    3. (1 articles) Conavi Medical Inc.
    4. (1 articles) Leica
    5. (1 articles) Damae Medical
    6. (1 articles) Heidelberg Engineering
    7. (1 articles) NinePoint Medical
    8. (1 articles) Avinger
    9. (1 articles) Michelson Diagnostics
    10. (1 articles) Scinvivo